1383 Clinical Severity of Cerebral Proliferative Angiopathy: A Meta-Analysis Highlighting its Significance Beyond Arteriovenous Malformations

INTRODUCTION: Cerebral Proliferative Angiopathy (CPA) is a rare subtype of brain arteriovenous malformations (AVM), mainly characterized by intermingled brain parenchyma with vascular network. Current evidence remains insufficient to decide on the best treatment principles and rationale for this somewhat newly categorized disease. Today, endovascular, revascularization surgery, radiotherapy and conservative strategies have been proposed. Moreover, a gap in morbimortality exists, in comparison with approaches for brain AVM management. METHODS: A meta-analysis was conducted according to PRISMA guidelines. For this, we elected PubMed, Embase and Web Of Science as databases. Keywords, such as “cerebral proliferative angiopathy” and “management” were utilized. We pooled and meta-analyzed outcomes on documented CPA cases. RESULTS: 11079 studies were pooled, 50 studies were included, adding up to 115 CPA cases. The majority of patients were females (1.38:1), with a mean age of presentation of 27 (19) years. Headache (46%) were the most common presenting symptom. 37% of patients presented with focal neurologic deficit (FND), and 34% with seizures. Patients managed conservatively experienced major complications in 47% of cases (95% CI: 17%, 76%), with a 1% mortality (95% CI: 0%, 6%). Surgical and embolization interventions presented the highest proportion of major complications: 66% (95% CI: 33%, 99%) and 73% (95% CI: 42%, 100%), respectively. The embolization subgroup led in mortality, with 3% (95% CI: 0%, 10%). No death was documented in patients undergoing revascularization surgery. CONCLUSIONS: CPA clinical presentation can be compatible with brain arteriovenous malformations, with headaches, seizures and FND. However, our meta-analysis revealed treatment outcomes are potentially worse. This gap is not entirely explained by differences in patient profiles undergoing different treatment strategies, rendering special attention to diagnostic methods.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_1383
Primary Topic
Vascular Malformations Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1383 Clinical Severity of Cerebral Proliferative Angiopathy: A Meta-Analysis Highlighting its Significance Beyond Arteriovenous Malformations

Sávio Batista, Laura Britz Soares, Michael T. Lawton, Lucas Pari Mitre et al.
Neurosurgery
Vascular Malformations Diagnosis and Treatment
article

1383 Clinical Severity of Cerebral Proliferative Angiopathy: A Meta-Analysis Highlighting its Significance Beyond Arteriovenous Malformations

Sávio Batista, Laura Britz Soares, Michael T. Lawton, Lucas Pari Mitre, Luís G. Pinheiro Neto, Lucca B. Palavani, Felipe L. Pereira, Leonardo de Macêdo Filho, M. S. Ferreira, Gabriel Semione, Miguel Vieira de Almeida, Eberval Gadelha Figueiredo, Carlos Alexandre Farias, Raphael Bertani
article en

Abstract

INTRODUCTION: Cerebral Proliferative Angiopathy (CPA) is a rare subtype of brain arteriovenous malformations (AVM), mainly characterized by intermingled brain parenchyma with vascular network. Current evidence remains insufficient to decide on the best treatment principles and rationale for this somewhat newly categorized disease. Today, endovascular, revascularization surgery, radiotherapy and conservative strategies have been proposed. Moreover, a gap in morbimortality exists, in comparison with approaches for brain AVM management. METHODS: A meta-analysis was conducted according to PRISMA guidelines. For this, we elected PubMed, Embase and Web Of Science as databases. Keywords, such as “cerebral proliferative angiopathy” and “management” were utilized. We pooled and meta-analyzed outcomes on documented CPA cases. RESULTS: 11079 studies were pooled, 50 studies were included, adding up to 115 CPA cases. The majority of patients were females (1.38:1), with a mean age of presentation of 27 (19) years. Headache (46%) were the most common presenting symptom. 37% of patients presented with focal neurologic deficit (FND), and 34% with seizures. Patients managed conservatively experienced major complications in 47% of cases (95% CI: 17%, 76%), with a 1% mortality (95% CI: 0%, 6%). Surgical and embolization interventions presented the highest proportion of major complications: 66% (95% CI: 33%, 99%) and 73% (95% CI: 42%, 100%), respectively. The embolization subgroup led in mortality, with 3% (95% CI: 0%, 10%). No death was documented in patients undergoing revascularization surgery. CONCLUSIONS: CPA clinical presentation can be compatible with brain arteriovenous malformations, with headaches, seizures and FND. However, our meta-analysis revealed treatment outcomes are potentially worse. This gap is not entirely explained by differences in patient profiles undergoing different treatment strategies, rendering special attention to diagnostic methods.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 92%
Vascular Malformations Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.